机译:Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer
Institute of Cancer Stem Cells and Second Affiliated Hospital,Dalian Medical University;
Department of Immunology, College of Basic Medical Sciences,Dalian Medical University;
School of Medicine,Southern University of Science and TechnologyDepartment of Pathology, First Affiliated Hospital,Dalian Medical UniversityInstitute of Genome Engineered Animal Models for Human Diseases,Dalian Medical UniversityCAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical;